RxDoctor Payments Data

Anthony Portale

Pediatrics · San Francisco, CANPI 1861433989

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (56.5%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Kyowa Kirin, Inc. accounts for 61.0% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $96,154, more than ten times the $8,807 reported in 2019. Among pediatrics clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$353,692in general payments, 2019–2025

Across 367 payments — averaging $963.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kyowa Kirin, Inc.$216K
  • Ultragenyx Pharmaceutical Inc.$125K
  • Biomarin Pharmaceutical Inc.$6K
  • Akebia Therapeutics Inc$5K
  • Kyowa Kirin Services Ltd$2K
$878,521in research payments, 2019–2025

Across 83 payments — averaging $10,585 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Ultragenyx Pharmaceutical Inc.$879K

What the payments were for

  • Consulting fees$106,58730%
  • Speaking & faculty fees$199,90357%
  • Travel & lodging$41,23912%
  • Food & beverage$5,9032%
  • Education$600%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$353,692 in reported general payments places this provider in the 95th percentile of 5,539 pediatrics providers in California.

See all pediatrics providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam20$75

Paid to pharmacies, not to this prescriber.

Other pediatrics in San Francisco

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →